Douglas M. Wolf

2.3k total citations
21 papers, 1.9k citations indexed

About

Douglas M. Wolf is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Douglas M. Wolf has authored 21 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 12 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Douglas M. Wolf's work include Estrogen and related hormone effects (14 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer-related Molecular Pathways (3 papers). Douglas M. Wolf is often cited by papers focused on Estrogen and related hormone effects (14 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer-related Molecular Pathways (3 papers). Douglas M. Wolf collaborates with scholars based in United States, United Kingdom and Sweden. Douglas M. Wolf's co-authors include V. Craig Jordan, Suzanne A.W. Fuqua, Kathryn B. Horwitz, Nicole Manning, Britta M. Jacobsen, Jennifer K. Richer, Kimberly K. Leslie, Steffi Oesterreich, Åke Borg and Qiuxia Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Oncogene.

In The Last Decade

Douglas M. Wolf

21 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas M. Wolf United States 17 1.0k 939 629 292 263 21 1.9k
Oliver Treeck Germany 25 732 0.7× 734 0.8× 543 0.9× 340 1.2× 115 0.4× 87 1.7k
Dany Chalbos France 34 1.2k 1.2× 1.7k 1.8× 991 1.6× 815 2.8× 173 0.7× 58 3.0k
Raphael C. Guzman United States 25 822 0.8× 1.3k 1.4× 1.2k 1.9× 432 1.5× 120 0.5× 49 2.6k
Boris J. Cheskis United States 17 1.1k 1.1× 909 1.0× 339 0.5× 135 0.5× 158 0.6× 18 1.7k
Patricia V. Elizalde Argentina 28 489 0.5× 1.1k 1.1× 1.0k 1.6× 478 1.6× 131 0.5× 60 2.1k
D. P. McDonnell United States 9 1.4k 1.4× 608 0.6× 284 0.5× 115 0.4× 102 0.4× 13 1.9k
B W O'Malley United States 14 1.5k 1.4× 900 1.0× 323 0.5× 136 0.5× 65 0.2× 14 2.1k
Eileen M. McInerney United States 13 2.0k 2.0× 2.2k 2.3× 739 1.2× 487 1.7× 153 0.6× 13 3.4k
Wenlin Shao United States 14 754 0.7× 1.5k 1.6× 480 0.8× 238 0.8× 147 0.6× 27 2.0k
Benjamin S. Leung United States 22 540 0.5× 409 0.4× 342 0.5× 185 0.6× 63 0.2× 53 1.3k

Countries citing papers authored by Douglas M. Wolf

Since Specialization
Citations

This map shows the geographic impact of Douglas M. Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas M. Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas M. Wolf more than expected).

Fields of papers citing papers by Douglas M. Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas M. Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas M. Wolf. The network helps show where Douglas M. Wolf may publish in the future.

Co-authorship network of co-authors of Douglas M. Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas M. Wolf. A scholar is included among the top collaborators of Douglas M. Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas M. Wolf. Douglas M. Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gibbs, Ronald S., Robert S. McDuffie, Mirjam Kunze, et al.. (2004). Experimental intrauterine infection with Prevotella bivia in New Zealand White rabbits. American Journal of Obstetrics and Gynecology. 190(4). 1082–1086. 23 indexed citations
2.
Dai, Donghai, et al.. (2004). Immunomodulatory and Transcriptional Effects of Progesterone Through Progesterone A and B Receptors in Hec50co Poorly Differentiated Endometrial Cancer Cells. Journal of the Society for Gynecologic Investigation. 11(7). 494–499. 26 indexed citations
3.
4.
Coletta, Ricardo D., Kimberly Christensen, Justin Lamb, et al.. (2004). The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1. Proceedings of the National Academy of Sciences. 101(17). 6478–6483. 189 indexed citations
5.
Richer, Jennifer K., et al.. (2002). Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells. Journal of Biological Chemistry. 277(7). 5209–5218. 476 indexed citations
6.
Gibbs, Ronald S., Jill Davies, Robert S. McDuffie, et al.. (2002). Chronic intrauterine infection and inflammation in the preterm rabbit, despite antibiotic therapy. American Journal of Obstetrics and Gynecology. 186(2). 234–239. 20 indexed citations
7.
Dai, Donghai, Douglas M. Wolf, Elizabeth S. Litman, Michael J. White, & Kimberly K. Leslie. (2002). Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors.. PubMed. 62(3). 881–6. 134 indexed citations
8.
Dai, Donghai, et al.. (2001). Molecular tools to reestablish progestin control of endometrial cancer cell proliferation. American Journal of Obstetrics and Gynecology. 184(5). 790–797. 39 indexed citations
9.
Bhatia, Neehar, Jifu Zhao, Douglas M. Wolf, & Rajesh Agarwal. (1999). Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin. Cancer Letters. 147(1-2). 77–84. 145 indexed citations
10.
Levenson, Anait S., Douglas M. Wolf, William H. Catherino, Hiroyuki Takei, & V. Craig Jordan. (1998). Understanding the antiestrogenic actions of raloxifene and a mechanism of drug resistance to tamoxifen. Breast Cancer. 5(2). 99–106. 7 indexed citations
11.
Zhang, Qiuxia, Åke Borg, Douglas M. Wolf, Steffi Oesterreich, & Suzanne A.W. Fuqua. (1997). An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer.. PubMed. 57(7). 1244–9. 221 indexed citations
12.
Bilimoria, Malcolm M., et al.. (1996). An analysis of tamoxifen-stimulated human carcinomas for mutations in the AF-2 region of the estrogen receptor. The Journal of Steroid Biochemistry and Molecular Biology. 58(5-6). 479–488. 15 indexed citations
13.
Wolf, Douglas M. & Suzanne A.W. Fuqua. (1995). Mechanisms of action of antiestrogens. Cancer Treatment Reviews. 21(3). 247–271. 21 indexed citations
14.
Fuqua, Suzanne A.W. & Douglas M. Wolf. (1995). Molecular aspects of estrogen receptor variants in breast cancer. Breast Cancer Research and Treatment. 35(3). 233–241. 50 indexed citations
15.
Jordan, V. Craig, William H. Catherino, & Douglas M. Wolf. (1995). A Mutant Receptor as a Mechanism of Drug Resistance to Tamoxifen Treatmenta. Annals of the New York Academy of Sciences. 761(1). 138–147. 2 indexed citations
16.
Wolf, Douglas M. & V. Craig Jordan. (1994). Characterization of tamoxifen stimulated MCF-7 tumor variants grown in athymic mice. Breast Cancer Research and Treatment. 31(1). 117–127. 61 indexed citations
17.
Wolf, Douglas M. & V. Craig Jordan. (1994). The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain. Breast Cancer Research and Treatment. 31(1). 129–138. 119 indexed citations
18.
Wolf, Douglas M. & V. Craig Jordan. (1993). Drug resistance to tamoxifen during breast cancer therapy. Breast Cancer Research and Treatment. 27(1-2). 27–40. 35 indexed citations
19.
Wolf, Douglas M. & V. Craig Jordan. (1992). Gynecologic complications associated with long-term adjuvant tamoxifen therapy for breast cancer. Gynecologic Oncology. 45(2). 118–128. 60 indexed citations
20.
Wolf, Douglas M., et al.. (1992). An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol. Molecular and Cellular Endocrinology. 90(1). 77–86. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oliver Treeck Breakdown of academic impact, for papers by Dany Chalbos Breakdown of academic impact, for papers by Raphael C. Guzman Breakdown of academic impact, for papers by Boris J. Cheskis Breakdown of academic impact, for papers by Patricia V. Elizalde Breakdown of academic impact, for papers by D. P. McDonnell Breakdown of academic impact, for papers by B W O'Malley Breakdown of academic impact, for papers by Eileen M. McInerney Breakdown of academic impact, for papers by Wenlin Shao Breakdown of academic impact, for papers by Benjamin S. Leung
Rankless by CCL
2026